Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-Refractory Acute Graft Versus Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01442233
What this trial is testing

Plasma Exchanges in Multiple Sclerosis (MS) Relapses

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Acute Relapsing
University Hospital, Bordeaux 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602751
What this trial is testing

FMT for Pediatric SR-aGVHD

Who this might be right for
Acute Graft Versus Host Disease in Intestine
Bambino Gesù Hospital and Research Institute 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Testing effectiveness (Phase 2)Ended earlyNCT00032773
What this trial is testing

Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

Who this might be right for
Acute Graft Versus Host Disease
Astex Pharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06343792
What this trial is testing

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease

Who this might be right for
Steroid Refractory GVHD
ReAlta Life Sciences, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT01700036
What this trial is testing

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease

Who this might be right for
Graft vs Host Disease
University of Michigan Rogel Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02997280
What this trial is testing

Ruxolitinib for Steroid-refractory GVHD

Who this might be right for
Graft Vs Host Disease
St. Petersburg State Pavlov Medical University 75
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Early research (Phase 1)Study completedNCT03327857
What this trial is testing

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-Host DiseaseTreatment-refractory Acute Graft-versus-Host Disease
AltruBio Inc. 37
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Testing effectiveness (Phase 2)WithdrawnNCT02694770
What this trial is testing

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

Who this might be right for
Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
AbGenomics B.V Taiwan Branch
Post-approval studies (Phase 4)Study completedNCT00574470
What this trial is testing

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

Who this might be right for
Graft vs Host Disease
University of Iowa 3
Not applicableStudy completedNCT05052385
What this trial is testing

ECP Combination Study

Who this might be right for
Steroid Refractory GVHD
European Society for Blood and Marrow Transplantation 319
Testing effectiveness (Phase 2)Study completedNCT02027805
What this trial is testing

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Who this might be right for
Graft vs Host Disease
Xenikos 20
Not applicableAvailableNCT04745637
What this trial is testing

Managed Access Programs for INC424, Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals
Early research (Phase 1)Ended earlyNCT04227938
What this trial is testing

ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD

Who this might be right for
Graft Vs Host Disease
Alpine Immune Sciences, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT02824653
What this trial is testing

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Who this might be right for
Graft Versus Host Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07568535
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease

Who this might be right for
GVHD - Graft-Versus-Host Disease
Mesoblast, Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00492921
What this trial is testing

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Who this might be right for
Graft Versus Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)Ended earlyNCT00038792
What this trial is testing

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
M.D. Anderson Cancer Center 7
Next Page